Related Experiment Video
Updated: Jan 29, 2026

Establishment and Culture of Patient-Derived Breast Organoids
Published on: February 17, 2023
Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies
Hazem Abdullah1, Ying Zhang1, Kathryn Kirkwood2
1School of Medicine, University of St Andrews, North Haugh, St Andrews KY16 9TF, UK.
Background:
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer and is marked by pronounced intra-tumoural heterogeneity that complicates therapeutic response. Patient-derived organoids offer a physiologically relevant model to capture this diversity and evaluate treatment effects. When integrated with spatial transcriptomics, they might enable the mapping of spatially resolved transcriptional and isoform-level changes within the tumour microenvironment.
Methods:
We established a robust workflow for generating patient-derived ccRCC organoids, that are not passaged and retain original cellular components. These retain key features of the original tumours, including cancer cell, stromal, and immune components.
Results:
Spatial transcriptomic profiling revealed multiple transcriptionally distinct regions within and across organoids, reflecting the intrinsic heterogeneity of ccRCC. Isoform-level analysis identified spatially variable expression of glutaminase (GLS) isoforms, with heterogeneous distributions of both the GAC and KGA variants. Treatment with NUC-7738, a phosphoramidate derivative of 3'-deoxyadenosine, induced marked transcriptional remodelling of organoids, including alterations in ribosomal and mitochondrial gene expression.
Conclusions:
This study demonstrates that combining long-read spatial transcriptomics with patient-derived organoid models provides a powerful and scalable approach for dissecting gene and isoform-level heterogeneity in ccRCC and for elucidating spatially resolved transcriptional responses to novel therapeutics.
Insights
Patient-derived organoids and spatial transcriptomics reveal clear cell renal cell carcinoma (ccRCC) heterogeneity. This approach maps gene expression changes and treatment responses within the tumor microenvironment.
Area of Science:
- Oncology
- Genomics
- Cancer Research
Background:
- Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer subtype, characterized by significant intra-tumoural heterogeneity complicating treatment.
- Patient-derived organoids (PDOs) provide a physiologically relevant model to study ccRCC diversity and treatment efficacy.
- Integrating PDOs with spatial transcriptomics allows for mapping spatially resolved transcriptional and isoform-level changes within the tumour microenvironment.
Purpose of the Study:
- To establish a robust workflow for generating patient-derived ccRCC organoids that retain original tumour components.
- To investigate the spatial heterogeneity of ccRCC using these organoids combined with spatial transcriptomics.
- To analyze the transcriptional and isoform-level responses to novel therapeutics within the tumour microenvironment.
Main Methods:
- Development of a workflow for generating patient-derived ccRCC organoids without passaging, preserving original cellular components (cancer, stromal, immune).
- Application of long-read spatial transcriptomics to profile organoids, identifying transcriptionally distinct regions.
- Isoform-level analysis to detect spatially variable gene expression, including glutaminase (GLS) isoforms.
Main Results:
- Spatial transcriptomic profiling revealed significant transcriptional heterogeneity within and across ccRCC organoids.
- Spatially variable expression of glutaminase (GLS) isoforms (GAC and KGA) was identified with heterogeneous distributions.
- Treatment with NUC-7738 induced substantial transcriptional remodelling in organoids, affecting ribosomal and mitochondrial gene expression.
Conclusions:
- The combination of long-read spatial transcriptomics and PDOs is a powerful, scalable method for dissecting ccRCC heterogeneity.
- This approach enables the elucidation of spatially resolved transcriptional and isoform-level responses to novel therapeutics.
- This methodology advances the understanding of ccRCC tumour microenvironment and therapeutic interventions.
Related Concept Videos
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Transcription Factors
Uncertainty in Measurement: Reading Instruments

